MILWAUKEE – Most residents and fellows who demonstrated racial bias did not report that race factored into treatment decisions.
The recall was issued because a small number of cartons labeled as containing 12 mcg/h patches contained 50 mcg/h patches.
PHILADELPHIA – In a field plagued by “squishy” data, standouts include neuropathic pain, nausea, spasticity, and...
The label changes are intended to be used when both the clinician and patient have agreed to reduce the opioid dosage.
The pair of injections mainly works by encouraging new bone formation.
MILWAUKEE – The two aims of research under the initiative are to improve treatments for misuse and addiction, and to enhance pain management.
MILWAUKEE – Tackling comorbid anxiety reduced pain, disability, and anxiety.
Misdiagnosis can result in increased loss of play time and chronic ankle dysfunction. Here are the physical exam maneuvers and imaging options to...
Many people endure a menacing or violent romantic partner—yet few physicians ask about this risk, or actual harm. Here is a roadmap for screening...
From the Journals
Results from the phase 3 RituxME trial found no difference in fatigue score symptoms after 24 months.
“Methadone, buprenorphine, and extended-release naltrexone ... save lives” but most people with OUD get no treatment, new report says.